Sign In

Christopher Park

Consulting Staff Scientist for Emerging Solutions at Illumina and 858 Therapeutics

Professional Background

Christopher Park is a distinguished bioinformatics scientist specializing in cancer genomics and epigenetics. With over 20 years of experience in the fields of genomics, molecular biology, and genetics, Christopher has become a leading figure in the research community. His expertise encompasses the analysis of large multi-scale genomic datasets, and he is proficient in programming languages such as R and utilizing Linux for data processing and analysis. Christopher's innovative approach has led him to develop cloud-based pipelines that facilitate the mapping and analysis of various types of genomic data, which include but are not limited to DNA sequencing, ChIP sequencing, RNA sequencing, bisulfite sequencing, and single-cell RNA sequencing experiments.

His extensive background also includes hands-on experience in production DNA sequencing and laboratory automation. Christopher has dedicated four years to refining his technical skills in this domain, which further complements his analytical capabilities. His training encompasses seven years in academic research, spanning diverse topics such as the genetics of gene regulation in mammalian cells, gene networks, and the intricate biology of fear. This blend of theoretical knowledge and practical application positions Christopher as an expert in developing innovative solutions to address complex biological questions.

Christopher is presently focused on epigenetic drug development and the assay development necessary to identify pharmacodynamic biomarkers for cancer therapeutics. His work demonstrates a commitment to translating genomic research into practical applications that can advance the field of personalized medicine.

Education and Achievements

Christopher Park's educational journey is marked by prestigious institutions and a strong foundation in the biological sciences. He obtained a Bachelor of Arts in Biological Basis of Behavior from the University of Pennsylvania, a program known for its integration of biology and psychology. Furthering his academic credentials, he pursued a Ph.D. in Molecular and Medical Pharmacology at the University of California, Los Angeles (UCLA), where he was exposed to advanced research methodologies and critical investigative techniques.

In addition to his formal education, Christopher has accumulated a wealth of practical experience through his roles across various esteemed organizations. He has served as a Senior Bioinformatics Scientist at Bristol-Myers Squibb, where he played a significant role in advancing bioinformatics strategies for cancer therapeutics. His contributions at Celgene, first as a Senior Scientist in Research Analytics and then in Bioinformatics at Celgene Quanticel Research, further enhanced his reputation as a leader in bioinformatics research.

Throughout his career, Christopher has been involved in numerous research projects that required not only technical skills but also the ability to collaborate effectively with multi-disciplinary teams. His previous roles, including Customer Support Scientist at Complete Genomics and Postdoctoral Fellow in Genetics at UCLA, showcase his adaptability and proficiency in bridging the gap between research and application.

Achievements

Christopher's achievements extend beyond his professional experience. He has exhibited a profound ability to innovate within the field of bioinformatics. A notable accomplishment includes the design and development of an interactive web application that allows researchers to analyze and visualize data from single-cell qPCR studies effectively. This tool enhances data interpretation and aids scientists in understanding complex genomic datasets.

In addition to his technical contributions, Christopher's ongoing research in epigenetic drug development highlights his commitment to advancing cancer therapeutics and his focus on identifying biomarkers that can lead to better patient outcomes. His work in this area not only contributes to academic knowledge but also paves the way for future clinical applications that could benefit a wide range of patients. Christopher Park exemplifies a professional who combines robust academic training with extensive practical experience, making significant strides in the highly specialized field of bioinformatics. His career reflects a dedication to improving our understanding of cancer genomics and epigenetics and translating that knowledge into meaningful therapeutic advancements.

Related Questions

How did Christopher Park develop his expertise in cancer genomics and epigenetics?
What are some of the significant projects Christopher Park has led during his time as a Senior Bioinformatics Scientist?
How does Christopher Park utilize cloud-based systems for genomic data analysis?
What strategies does Christopher Park employ in his current research on epigenetic drug development?
In what ways has Christopher's educational background influenced his professional trajectory in bioinformatics?
How has Christopher's experience at Bristol-Myers Squibb shaped his approach to bioinformatics in cancer research?
Can Christopher Park share insights on the importance of pharmacodynamic biomarkers in cancer therapeutics?
What innovative techniques in laboratory automation has Christopher Park implemented during his career?
What role does Christopher see bioinformatics playing in the future of personalized medicine?
How does Christopher Park envision the evolution of cancer genomics over the next decade?
Christopher Park
Add to my network

Location

San Francisco, California, United States